electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClubGlobeNewsWire · 3 days ago
electroCore (NASDAQ:ECOR) and Enovis (NYSE:ENOV) Head-To-Head ComparisonDefense World · Oct 6, 2026
electroCore Has A Line Of Sight At Cash BreakevenSeeking Alpha · Sep 26, 2026
Thomas Errico Purchases 5,000 Shares of electroCore (NASDAQ:ECOR) StockDefense World · Sep 24, 2026
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?Zacks Investment Research · Sep 18, 2026
electroCore to Participate at H.C. Wainwright Global Investment ConferenceGlobeNewsWire · Sep 10, 2026electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.42 | -$0.33 | Beat |
| May 6, 2026 | -$0.59 | -$0.59 | Beat |
| Mar 19, 2026 | -$0.35 | -$0.34 | Beat |
| Nov 5, 2025 | -$0.36 | -$0.40 | Miss |
| Aug 6, 2025 | -$0.32 | -$0.35 | Miss |
| May 7, 2025 | -$0.56 | -$0.47 | Beat |